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The aimof this studywas to evaluate if antibiotic prophylaxis reduces the bacterial contamination of bone particles collected directly
from the burs used for implant site preparation. Thirty-four patients underwent the surgical procedures for a total of 34 implant
sites. One 1 gr. tablet of amoxicillin + clavulanic acid was given to the test group 12 hours and 1 hour before the surgery.The control
group did not take antibiotic prophylaxis. Bone particles were collected and centrifuged. The suspensions were subjected to serial
dilutions and each dilution was examined twice using a spatulation technique in Trypticase Soy Agar (TSA), in SabouraudDextrose
Agar, and in Mitis Salivarius Agar (MSA).The number of colonies was calculated and the identification of various microorganisms
was made. The most represented species, in both groups of patients, belonged to the “oral Streptococci.” For TSA, the test and
control groups differed significantly (p = 0.018). Conversely, there was no significant difference for MSA (p = 0.201) and for the
number of bacterial species isolated in the samples of the two groups of patients (p = 0.898). The antibiotic prophylaxis reduced,
but did not cancel, the risk of infection of the autogenous particulate bone graft.This trial is registered with IRCT2017102537002N1.
1. Introduction
An important premise for the long-term success of implant
supported prosthetic restoration, including implant over-
dentures, is a proper implant placement in a sufficient
volume of healthy bone recipient [1, 2]. The implant surface
and sufficient amount of bone in the implants beds are
currently considered two of the most important factors for
osseointegration [3, 4]. During the surgical placement of the
implant fixtures, peri-implant defects such as dehiscences or
fenestrations can occur; this may be due to the bone anatomy
of an edentulous area, where bone volume is frequently
lacking as a result of trauma, tooth loss, or infection diseases
such as chronic periodontitis. In all of these situations, bone
regeneration of the defect would improve the long-term
prognosis for the implant [3, 5, 6].
Among graft materials currently used to correct bone
defects, autologous bone is described as the gold standard
one, as it has biocompatibility, osteoinductive and osteo-
conductive properties, without immunological reactions, and
extra cost for purchasing biomaterials [3, 5, 7, 8]. In the
presence of small bone defects, the bone particles produced
during the preparation of the implant site could be used
to cover the exposed implant surface [3, 5]. Therefore,
a valuable surgical protocol should contemplate collecting
bone particles during the implant site preparation [9].
Worthy of note, the bacterial contamination of collected
bone may occur, due to the high bacterial charge of the
saliva that reaches values of 109 CFU/mL [10–13]. In bone
particles collected during dental implant surgery, pathogen
bacterial species, such as Enterococcus faecalis and Staphy-
lococcus epidermidis, have been isolated [10, 11]. It has also
been suggested that bacterial contamination of the bone
debris may be a cause of failure of osseointegration of the
implants, due to the increased local inflammatory response
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that compromises the healing of the bone [14]. A number of
studies have suggested different methods to reduce bacterial
contamination of the collected bone: antibiotic prophylaxis,
disinfection of the oral mucosa before the surgery, use of
specific bone collectors, stringent aspiration protocol, or
surgical techniques [10, 11, 15–17]. Among these, antibiotic
prophylaxis has been suggested as useful when collecting
bone particles for bone augmentation [16, 18]. Nevertheless,
the role of antibiotic prophylaxis to reduce bacterial contam-
ination of bone particles is still controversial, due to the small
number of heterogeneous studies published on the topic.
The aim of this study was to evaluate if a protocol
of antibiotic prophylaxis reduces the physiologically occur-
ring bacterial contamination of the bone particles collected
directly from the burs used for preparation of the implant site.
2. Materials and Methods
This study protocol conformed to the ethical guidelines of
the 1964 Declaration of Helsinki and its later amendments
or comparable ethical standards and was approved by insti-
tutional review board of the University of Palermo General
Hospital (AOU Policlinico Paolo Giaccone; approval number
8/2014). The study was registered at Iranian Registry of
Clinical Trials (IRCT2017102537002N1).
Eligibility criteria for participants and setting were as
follows: a need to replace the absence of one tooth with an
implant supported prosthesis, no systemic contraindications
to surgical procedures, no pregnancy, no history of antibiotic
therapy for 6 months prior to the study, no allergy to
penicillin or related drugs, absence of carious lesions and
local active inflammatory conditions or chronic/aggressive
periodontitis, and presence of alveolar ridges of class II or III
of Cawood and Howell [19]. Exclusion criteria included sys-
temic diseases that affect jaws and periodontium, orthodontic
appliance, active dental caries, chronic diseases of the oral
mucosa, chronic antibiotic usage, antiplaque mouthrinse
consumption, drugs consumption which affect saliva flow
rate, and radiotherapy history.
In the period between September 2014 and February 2015,
34 patients (14 men and 20 women, mean age: 49.7) were
selected and underwent the same surgical procedures, for a
total of 34 implant sites. All the procedures were performed
at the University of Palermo General Hospital; after being
informed, patients signed written consent for both surgical
treatment and the experimental study.
Fifteen days before the surgery, all patients were subjected
to an oral hygiene session and instructed to perform correct
domiciliary oral hygiene, improved with 0.2% chlorhexi-
dine mouthrinses (Meridol Clorexidina, Colgate-Palmolive,
Roma, Italy) after tooth brushing twice a day.
Patients were randomly divided into two groups using a
predetermined computer-generated randomization scheme.
Antibiotic prophylaxis was prescribed to the test group,
consisting of 18 patients, while the control group of 16 patients
did not take antibiotic prophylaxis at all. One 1 gr. tablet of
amoxicillin + clavulanic acid (Augmentin, GlaxoSmithKline,
Verona, Italy) was given to the test group patients 12 hours
and 1 hour before the surgery.
All surgical procedures were performed by the same
operator. Both the surgeon and assistants wore sterile gowns
and gloves, while the patients were fully covered with sterile
drapes in the usual manner. The lips and perioral facial skin
areas of the patients were disinfected with benzalkonium
chloride. Before surgery all the patients were asked to rinse
their mouth for 60 seconds with a chlorhexidine 0.2%
mouthrinse. After local anesthesia, a full-thickness flap was
made and the implant site was prepared with calibrated
drills (Intra-Lock International, Boca Raton, FL, USA) at 600
revolutions per minute, irrigated by cooled saline solution.
During each step of the calibrated drills, bone particles on
the coils were collected and placed in a 15ml sterile tube
containing 10ml of prereduced thioglycolate broth (Oxoid,
Cambridge, UK).
All implants were submerged, and they were exposed 3
months after implant placement, in order to complete the
implant-prosthetic treatment. Follow-up visits were sched-
uled at 1, 3, 6, and 12 months.
The collected samples were sent to the microbiology
laboratory within one hour. The tubes containing the bone
particles were centrifuged at 4000×g for 10 minutes at 4∘C.
Under a laminar flow hood, the supernatant was removed
from the tubes and the bone particles, after being weighed,
were resuspended in 2ml of sterile PBS solution at pH 7.4
and transferred to a new sterile tube. The suspensions were
subjected to serial dilutions (from 10−1 to 10−4) and 100 𝜇l
of each dilution was examined twice, using the spatulation
technique, in Trypticase Soy Agar (TSA) for total counts
of microorganisms, in Sabouraud Dextrose Agar (SDA) for
yeast-form cell counts, and inMitis SalivariusAgar (MSA) for
streptococci isolation. TSA and SDA plates were incubated
at 37 ± 1∘C for 48 h in aerobic conditions; MSA plates were
placed in an incubator within a controlled atmosphere, at 5%
CO2 and 37
∘C ± 1 for 96 hours.
The number of colonies present on the different culture
medium was multiplied by the dilution factor of the sample.
The numbers of colony forming units per bone samples
(CFU/g) were calculated according to Ku¨rkc¸u¨ et al. [16].
The identification of the various microorganisms on pure
cultures, obtained from subtransplants in nonselective media
(diagnostic sensitivity test agar, DSTA), was made using
morphological criteria, microscopic observation after Gram
staining, and biochemical tests: catalase, coagulase, and API
Identification Systems (bioMe´rieux, Marcy l’Etoile, France).
Moreover, the Blood Agar Medium was used for the Gram-
positive and catalase negative colonies to emphasize the
presence and type of hemolysis.
2.1. Statistical Analysis. Abnormally distributed quantitative
variables were log-transformed and summarized as median
and interquartile range (IR). Counts and proportions were
calculated for qualitative variables. Frequencies were ana-
lyzed using Fischer’s exact test whereas medians were com-
pared using theWilcoxon rank-sum test. Data were analyzed
using Stata/SE 14.1 (Stata Corporation, College Station, TX,
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Table 1: Clinical features of test and control groups.
Test group𝑁 = 18 Control group𝑁 = 16 𝑝 value
Age (Me (𝑄1–𝑄3)) 53.5 (47.0–51) 50.0 (49.5–58.0) 0.261
Smoking status yes [𝑛 (%)] 5 (27.8) 5 (31.3) 0.824
Comorbidity yes [𝑛 (%)] 4 (22.2) 4 (25.0) 1.000
Me = median;𝑄1–𝑄3 = interquartile range.
Table 2: Detection frequency of bacterial species in test and control groups.
Species Test group Control group
Streptococcus mitis 38.8% 31.2%
Streptococcus acidominimus 33% 31.2%
Streptococcus uberis 22.2% 18.7%
Streptococcus morbillorum 16.6% 18.7%
Streptococcus constellatus 16.6% 0%
Streptococcus mutans 5.5% 6.25%
Streptococcus oralis 5.5% 0%
Streptococcus sanguis 5.5% 0%
Streptococcus anginosus 5.5% 0%
Coagulase-negative Staphylococcus 0% 12.5%
Enterococcus faecalis 11.1% 12.5%
Lactobacillus salivarius 0% 22.2%
Streptococcus intermedius 0% 12.5%
Candida albicans 0% 6.25%
Gemella haemolysans 0% 6.25%
USA). Statistical significance was defined as 𝑝 ≤ 0.05, two-
tailed.
3. Results
The test and control groups did not differ significantly for
age and clinical variables (Table 1). All the implants placed
successfully complete the osseointegration process, without
any complications during healing period.No prosthesis failed
during the entire follow-up, and nomajor complicationswere
recorded.
The most represented species, in both groups of patients,
belonged to the group of bacteria called “oral streptococci.”
The most frequently isolated microorganisms in both groups
are listed in Table 2 and Figure 1: Streptococcus mitis (test
group 38.8%; control group 31.2%), Streptococcus acidomin-
imus (test group 33.3%; control group 31.2%), Streptococ-
cus uberis (test group 22.2%; control group 18.7%), and
Streptococcus morbillorum (test group 16.6%; control group
18.7%). Other microorganisms found in both test and control
groups were Streptococcus mutans (test group 5.5%; control
group 6.25%) and Enterococcus faecalis (test group 11.1%;
control group 12.5%). Streptococcus oralis (5.5%), Streptococ-
cus sanguis (5.5%), and Streptococcus anginosus (5.5%) were
found only in the test group, whereas Streptococcus salivarius
(18.7%), coagulase-negative Staphylococcus (12.5%), Strepto-
coccus intermedius (12.5%), Gemella haemolysans (6.25%),
and Candida albicans (6.25%) were found only in the control
group.
The median (IR) values of the test group were 1.71
(0.78–1.91) in the TSA and 1.03 (0.60–1.78) in the MSA,
whereas in the control group they were 2.12 (1.15–3.42) and
1.62 (0.82–3.03), respectively. For TSA, the test and control
groups differed significantly (𝑝 = 0.018). Conversely, there
was no significant difference for MSA (𝑝 = 0.201) and for the
number of bacterial species isolated in the samples of the two
groups of patients (𝑝 = 0.898) (Table 3).
4. Discussion
Oral surgical procedures are often graded as class II (clean-
contaminated surgery), with a rate of local infection of
10–15% [20, 21]. This rate could be higher in implant surgery,
particularly when bone particles harvested in bone collectors
are used in presence of exposed implant fixtures (“simultane-
ous augmentation technique”) [22].
As bone particles are always contaminated by bacteria,
their use could promote the formation of a bacterial biofilm at
the level of the peri-implant tissues, affecting the result of the
bone regeneration technique and reducing the success rate of
the implant therapy [10, 16, 23–27].
The use of stringent aspiration protocol and the pre-
operative rinsing with chlorhexidine mouthrinse has been
demonstrated to minimize bacterial contaminants, but none
of these methods are able to completely eliminate bacterial
contamination of bone particles [10, 11, 15–17]. Conversely, a
number of authors recommended that patients should receive
prophylactic antibiotic treatment as a routine protocol before
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Figure 1: Bacterial species isolated in the samples of the two groups of patients.
Table 3: Microbiological findings in test and control groups.
Characteristics Test group
𝑁 = 18
Control group
𝑁 = 16
𝑝 value
TSA log (Me (𝑄1–𝑄3))
1.71
(0.78–1.91) 2.12 (1.15–3.42) 0.018
∗
MSA log (Me (𝑄1–𝑄3)) 1.03 (0.60–1.78) 1.62 (0.82–3.03) 0.201
Bacterial species isolated (𝑛 (%))
0 species
1 species
2 species
3 species
4 species
3 (16.7)
7 (38.9)
4 (22.2)
3 (16.7)
1 (5.6)
1 (6.3)
6 (37.5)
5 (31.3)
3 (18.8)
1 (6.3)
0.898
∗Statistically significant difference; Me = median;𝑄1–𝑄3 = interquartile range.
undergoing intraoral bone augmentation procedures with
bone particles harvested with bone traps [11, 15, 18, 28–34].
In this study, we evaluated the efficacy of an antibiotic
prophylaxis regimen (one 1 gr. tablet of amoxicillin plus
clavulanic acid 12 hours and 1 hour before the surgery) on
the bacterial contamination of the bone particles harvested
during the preparation of the implant site. Oral Gram-
positive andGram-negative bacteria are largely susceptible to
amoxicillin-clavulanate, and amoxicillin is usually the drug
of choice within the beta-lactam family because it is better
absorbed, following oral administration, than other beta-
lactam antibiotics [35]. All the patients underwent a pre-
operative oral rinse with 0.2% chlorhexidine, but antibiotic
prophylaxiswas administered only in the test group.Thebone
particles were collected from the calibrated burs used for
the preparation of the implant site, without the use of bone
collectors.
Our results showed bacterial contamination in all the
bone particle samples analyzed. Similarly, to the results
reported by Young et al. [10], the species detected included
both commonly occurring and rare oral isolates. The most
frequently isolated bacteria belong to the group of “oral strep-
tococci” (Figure 1). Among these, Streptococcus constellatus
and Streptococcus mitis are considered potential responsible
for odontogenic infections. Streptococcus intermedius is an
anaerobic commensal bacterium, belonging to the S. angi-
nosus group. Moreover, despite being commensal organisms,
members of the S. anginosus group have been isolated
from patients with periodontitis [36]. Other microorganisms
isolated, not belonging to oral streptococci group, are Ente-
rococcus faecalis, Streptococcus uberis, and coagulase-negative
Staphylococcus. Despite the small number of samples, the
statistical analysis showed that when the nonselective culture
medium TSA was used, the CFU/g values of experimental
group were statistically lower than the control group (Fig-
ure 1). These findings suggest that the antibiotic prophylaxis
regimen being tested reduces the bacterial contamination of
the bone particles harvested during the preparation of the
implant site. A similar trend was found when the selective
culture medium for streptococci isolation was used, although
no significant differences in the CFU/g values were detected
between the test and control groups.This finding may be due
to the specific antibiotic prophylaxis regimen tested which
consists of only two administrations.
The use of prophylactic antibiotics in implant dentistry is
controversial. Esposito et al. [37], analyzing 6 studies included
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in a systematic review, suggested that 2 g or 3 g of amoxicillin
given orally, as a single administration, one hour preopera-
tively significantly reduces failure of dental implants due to
postoperative infection. Moreover, there is little research on
the extent to which a single dose of amoxicillin reaches the
surgical site and affects the oral microbiota, particularly the
salivary bacteria that are responsible for the contamination
of autogenous particulate bone graft [10, 11, 13, 17]. Larsson
et al. [38] found that a single dose of amoxicillin, given
as prophylaxis to prevent a surgical-site infection, results
in a significant reducing effect on the oral streptococcal
microflora in the gingival crevice, but not in saliva. The same
authors were not able to detect amoxicillin in saliva at all time
points after administration (1, 4, and 24 hours). On the other
hand, Baglie et al. [39] reported the presence of measurable
concentrations of amoxicillin in saliva until 8 hours after
a single administration of a 875mg tablet of amoxicillin.
Moreover, amoxicillin was effective in reducing oral bacteria
levels up to 12 hours’ after administration.
5. Conclusions
This study showed that the antibiotic prophylaxis regimen
tested (one 1 gr. tablet of amoxicillin plus clavulanic acid
12 hours and 1 hour before the surgery) reduces, but does
not eliminate, bone particulate contamination. The most
frequently isolated species belonged to the oral streptococci,
but even pathogen species were detected. Further clinical
research is needed to determine whether the antibiotic
prophylaxis regimen tested is effective in minimizing infec-
tions after dental implant placement when an autogenous
particulate bone graft is used.
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